Search clinical trials for: Refractory Rhabdomyosarcoma
Total 9271 results
-
National Cancer Institute (NCI)CompletedProstatic NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedBrain Neoplasms | NeuroblastomaUnited States
-
National Cancer Institute (NCI)CompletedB Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedGlioma | SarcomaUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCardiomyopathy, HypertrophicUnited States
-
National Institute of Mental Health (NIMH)CompletedBipolar DisorderUnited States
-
National Cancer Institute (NCI)CompletedMelanoma | Lymphoma | Renal Cell Carcinoma | Neoplasm MetastasisUnited States
-
National Institute of Mental Health (NIMH)Completed
-
National Institute of Allergy and Infectious Diseases...CompletedAtypical Mycobacterium InfectionUnited States
-
Hospital Universitari Son DuretaFondo de Investigacion SanitariaTerminatedTraumatic Brain InjurySpain
-
Myrexis Inc.CompletedBrain NeoplasmsUnited States
-
Myrexis Inc.CompletedRefractory Solid TumorsUnited States
-
Millennium Pharmaceuticals, Inc.CompletedColorectal CarcinomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedFollicular Lymphoma | B-Cell Lymphoma | Marginal LymphomaUnited States
-
SanofiCompletedNeoplasms, Germ Cell and EmbryonalFrance
-
Millennium Pharmaceuticals, Inc.CompletedMantle Cell LymphomaUnited States
-
Genentech, Inc.CompletedNon-Small-Cell Lung Carcinoma | Neoplasm Recurrence, LocalUnited States
-
University of VirginiaNational Cancer Institute (NCI)Terminated
-
Erimos PharmaceuticalsCompleted
-
SGX Pharmaceuticals, Inc.TerminatedAcute Myelogenous LeukemiaUnited States
-
Spectrum Pharmaceuticals, IncCompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
MedImmune LLCCambridge Antibody TechnologySuspendedLymphoma | LeukemiaUnited States
-
Cell GenesysCompleted
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompleted
-
Callisto PharmaceuticalsUnknownAcute Lymphocytic LeukemiaUnited States
-
Callisto PharmaceuticalsCompletedMultiple MyelomaUnited States
-
Astex Pharmaceuticals, Inc.Eisai Inc.CompletedChronic Myelogenous LeukemiaUnited States, Canada
-
University of AlbertaNovartisCompletedRefractory Ascites | Type 2 Hepatorenal SyndromeCanada
-
Seoul National University HospitalUnknownLupus NephritisKorea, Republic of
-
Accentia BiopharmaceuticalsCompleted
-
AbbottCompletedAdenocarcinoma | Prostate CancerCanada, United States, France, Netherlands, United Kingdom
-
University of WashingtonSanofiCompletedProstate CancerUnited States
-
Handok Inc.CompletedProstatic HyperplasiaKorea, Republic of
-
KangLaiTe USACompletedNeoplasms | Solid Tumors Refractory To Standard TherapyUnited States
-
PfizerCompletedDyslipidemia | Hypercholesterolemia | HyperlipidemiaUnited States
-
Keio UniversityTerminated
-
Cooperative Study Group A for HematologyUnknownLymphomaKorea, Republic of
-
Geriatric Oncology ConsortiumSanofiCompletedProstate CancerUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedWegener's Granulomatosis | Microscopic Polyangiitis | Churg-Strauss SyndromeFrance
-
University Hospital, BonnUnknownParoxysmal Atrial Fibrillation
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; International...Terminated
-
Gruppo Italiano MEsoteliomaUnknown
-
German AML Cooperative GroupUnknownRelapsed Acute Promyelocytic Leukemia | Refractory Acute Promyelocytic LeukemiaGermany
-
Swedish Medical CenterNovartisCompleted
-
Herlev HospitalEli Lilly and Company; SanofiCompleted
-
London North West Healthcare NHS TrustUnknownGastrointestinal Hemorrhage | Small Bowel Disease | Refractory AnemiaUnited Kingdom
-
Weintraub, Michael I., MD, FACP, FAANDr. Steven P. Cole, PhD. StatisticianCompletedRefractory Carpal Tunnel Syndrome | Neurpathic Pain | NeuromodulatonUnited States
-
Cytogen CorporationUnknownMetastatic Prostate CancerUnited States